Company Filing History:
Years Active: 2009-2010
Title: Regine Ritter: Innovator in Medicinal Chemistry
Introduction
Regine Ritter is a prominent inventor based in Wiesbaden, Germany. She has made significant contributions to the field of medicinal chemistry, particularly through her innovative work on crystalline forms of compounds used in the preparation of medicaments. With a total of 2 patents, her inventions reflect her dedication to advancing pharmaceutical science.
Latest Patents
Regine Ritter's latest patents include a crystalline form of 1'-(1-methylethyl)-4'–[(2-fluoro-4-methoxyphenyl)methyl]-5'–methyl-1H-pyrazol-3'–O-β-D-glucopyranoside. This invention not only describes the crystalline form but also outlines a method for its preparation and its application in the development of medicaments. The focus on this specific compound highlights her commitment to improving therapeutic options.
Career Highlights
Throughout her career, Regine Ritter has worked with notable companies in the pharmaceutical industry, including Ajinomoto Co., Ltd. and Boehringer Ingelheim International GmbH. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Regine has collaborated with esteemed colleagues such as Gerd Kraemer and Hans-Juergen Martin. These partnerships have played a crucial role in her innovative endeavors and have furthered her impact in medicinal chemistry.
Conclusion
Regine Ritter's work exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions through her patents and collaborations continue to influence the development of new medicaments.